H Narimatsu
Overview
Explore the profile of H Narimatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gazoni T, Haddad C, Narimatsu H, Cabral-de-Mello D, Lyra M, Parise-Maltempi P
Chromosoma
. 2018 Jan;
127(2):269-278.
PMID: 29372309
Heteromorphic sex chromosomes are common in eukaryotes and largely ubiquitous in birds and mammals. The largest number of multiple sex chromosomes in vertebrates known today is found in the monotreme...
2.
Ito Y, Narimatsu H, Fukui T, Fukao A, Yoshioka T
Ann Oncol
. 2013 Mar;
24(5):1297-305.
PMID: 23532113
Background: 'Public domain application' is a flexible drug approval system in Japan, similar to the fast track designation in the United States. Methods: From 1999 to 2009, four drugs and...
3.
Narimatsu H, Kakinuma A, Sawa T, Komatsu T, Matsumura T, Kami M, et al.
Ann Oncol
. 2011 Feb;
22(9):2121-2128.
PMID: 21285135
Background: We developed an e-learning system, which is based on an interactive animation video that assists anesthesiologists in preanesthetic interviews. Materials And Methods: First, the feasibility of the system was...
4.
Narimatsu H, Watanabe M, Kohno A, Sugimoto K, Kuwatsuka Y, Uchida T, et al.
Bone Marrow Transplant
. 2008 Jan;
41(8):753-6.
PMID: 18195683
No abstract available.
5.
Sugimoto K, Narimatsu H, Kawase T, Iida H, Watanabe M, Kohno A, et al.
Bone Marrow Transplant
. 2008 Jan;
41(8):729-36.
PMID: 18176617
Chronic GVHD is a significant complication following allogeneic hematopoietic stem cell transplantation; however, the clinical characteristics of chronic GVHD following cord blood transplantation (CBT) in adults have not been well...
6.
Narimatsu H, Yokozawa T, Iida H, Tsuzuki M, Hayakawa M, Takeo T, et al.
Leukemia
. 2007 Aug;
22(2):428-32.
PMID: 17713551
No abstract available.
7.
Narimatsu H, Emi N, Kohno A, Iwai M, Yanada M, Yokozawa T, et al.
Bone Marrow Transplant
. 2007 Aug;
40(8):773-8.
PMID: 17700597
Secondary failure of platelet recovery (SFPR), which is a delayed decline in platelet count after primary recovery following myeloablative hematopoietic SCT, is a significant problem in allogeneic SCT. However, its...
8.
Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T
Bone Marrow Transplant
. 2007 Apr;
40(1):85-7.
PMID: 17450178
No abstract available.
9.
Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E, et al.
Transpl Infect Dis
. 2007 Feb;
9(1):11-5.
PMID: 17313465
Although foscarnet is a promising alternative for the treatment of cytomegalovirus (CMV) infection, its toxicity can be significant in patients with advanced age. We retrospectively reviewed medical records of 123...
10.
Kami M, Murashige N, Tanaka Y, Narimatsu H
Transpl Infect Dis
. 2006 Nov;
8(4):190-202.
PMID: 17116132
Reduced-intensity stem cell transplantation (RIST) has been developed to be a novel curative option for advanced hematologic diseases. Its minimal toxicity allows for transplantation in patients with advanced age or...